ABAli Reza Bakhshandeh

Ali Reza Bakhshandeh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ali Reza Bakhshandeh has a total of 13 co-authors. Here are the top co-authors by number of shared publications:

  • Mehrdad Salehi

    Tehran University of Medical Sciences

    3 shared publications
  • Farangis Sarouneh Rigi

    Department of Cardiovascular Surgery, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran

    2 shared publications
  • Mehrzad Rahmanian

    Tehran University of Medical Sciences

    2 shared publications
  • Aso Ibrahim Ezzat

    Department of Cardiovascular Surgery, Imam Medical Complex, Tehran University of Medical Sciences, Tehran, Iran

    1 shared publication
  • Gholam Ali Riahi

    Department of Cardiovascular Surgery, Imam Medical Complex, Tehran University of Medical Sciences, Tehran, Iran

    1 shared publication
  • Hasan Radmehr

    Department of Cardiovascular Surgery, Imam Medical Complex, Tehran University of Medical Sciences, Tehran, Iran

    1 shared publication

Latest Publications

  • Resternotomy, a single-center experience

    by Mehrdad Salehi, Ali Reza Bakhshandeh, Kianoush Saberi, Mahmood Alemohammad, Keivan Sobhanian, Maziar Karamnezhad, Farangis Sarouneh Rigi

    Background: Reoperations are technically more difficult because of the risks associated with reentry in a heart with more advanced pathology, little reserve, and more frequent comorbidities. Routine peripheral cannulation before resternotomy is inadvisable, time-consuming, and has no noticeable role in decreasing the risks of reentry. We present our experience of resternotomy without routine peripheral cannulation. Methods: This was a retrospective study on 237 consecutive patients who underwent resternotomy between June 2011 and July 2013. Their mean age was 47.7 ± 18.2 years. We chose the best approach individually, according to lateral radiograph findings, patient risk factors, and previous surgery. Our goal was to observe events intraoperatively and their outcomes postoperatively. Results: Mean intensive care unit stay was 3.1 ± 0.9 days. Twenty-one (8.8%) patients died during their hospital stay. The most common cause of death was renal failure in 15 (71.4%) patients, coagulopathy in 4 (19%), and cardiac failure in 2 (9.5%). We had 3 right ventricular, one right atrial, one pulmonary artery, and 2 inferior vena caval tears during resternotomy and dissection; bleeding was controlled easily without peripheral cannulation. Femoral cannulation before resternotomy was performed in one patient who needed an emergency pulmonary embolectomy. Conclusions: Based on our experience, resternotomy with central cannulation is a safe strategy, and peripheral cannulation before resternotomy should be reserved for highly selected patients.


  • N-terminal pro-beta-type natriuretic peptide (NT-proBNP) can be considered a valuable predictor of heart rejection

    by Mehrdad Salehi, Ali Reza Bakhshandeh, Mehrzad Rahmanian, Farangis Sarouneh Rigi, Kianoush Saberi

  • Heart transplant survival rate in Iran: a single-center registry report

    by Mehrdad Salehi, Ali Reza Bakhshandeh, Sahar Latifi, Mehrzad Rahmanian

    Aim to determine 1-month and 1-year survival rate in recipients of heart transplants in Imam Khomeini Medical Center. Methods we analyzed the outcomes of 69 patients who underwent heart transplantation between 2007 and 2010. The 1-month and 1-year survival rates were calculated, and we assessed prognostic factors such as donor and recipient age and sex, graft ischemic time during surgery, and liver and kidney function tests. Results increased donor age had a significant negative effect on survival rate (p = 0.005). Sex differences between donor and recipient had no association with transplant outcome and survival rate. The overall 1-month and 1-year survival was 82.6% (n = 54) and 70% (n = 48), respectively. Conclusion heart transplantation is a lifesaving procedure for end-stage heart disorders. Mortality after heart transplantation depends on numerous factors, and thus survival rates differ among centers. The 1-month and 1-year survival rates after heart transplant in our center currently stand at 82.6% and 70%, respectively.


  • Short crossclamp heart transplantation: a modified technique

    by Ali Reza Bakhshandeh, Mehrdad Salehi, Hasan Radmehr, Aso Ibrahim Ezzat, Gholam Ali Riahi

    Prolongation of the ischemic time in heart transplantation adversely affects the performance of the donor heart. We compared the impact of ischemic time in 30 patients who had the conventional bicaval method with declamping just after the last anastomosis (group A) and 28 who had a modified short crossclamp technique with declamping after left atrial stump, aorta, and inferior vena caval anastomosis (group B). In the operating room, 4 (13.3%) group A patients need one inotropic and 26 (86.6%) need 2 or more; one (3.3%) needed intraaortic balloon pumping. In group B, one inotropic was used in 7 (25%) patients, 4 (14.2%) need 2 or more, and 17 (60.7%) needed no inotropic. Mean crossclamp time was 80.5 ± 4.7 min in group A and 62.4 ± 5.8 min in group B. Weaning from bypass was faster in group B. Transesophageal echocardiography at the end of the operation showed more complete de-airing in group B. There were no significant differences in intensive care unit stay or the incidence of postoperative neurologic complications between the 2 groups. Easier separation from bypass, even without a hot shot, and better echocardiographic systolic parameters postoperatively are the advantages of this modified technique.